Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PaySign (PAYS)
NASDAQ:PAYS
Holding PAYS?
Track your performance easily
Earnings Data
Report Date
Mar 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.02Last Year’s EPS
0.1Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 07, 2019
|% Change Since: -20.63%
|Next Earnings Date:Mar 11, 2019
Earnings Call Sentiment|Positive
Paysign's third quarter showed strong growth in revenue and significant expansion in the patient affordability business, which offset challenges in the plasma donor compensation segment and increased operating expenses. The company's strategic partnerships and strong cash position further reinforced its positive outlook.Company Guidance
During the Paysign, Inc.'s Q3 2024 earnings call, substantial growth metrics were highlighted, indicating a strong financial performance. Revenue for the quarter increased by 23% year-over-year to $15.3 million, with a 6.5% rise from the previous quarter. The adjusted EBITDA saw a 20.6% growth, reaching $2.8 million or $0.05 per share, up from $2.4 million or $0.04 per share a year prior. Gross margins improved significantly by 440 basis points, reaching 55.5%, largely driven by the patient affordability business, which saw a 219% revenue surge to $3.3 million. The plasma donor compensation business reported a modest 3.4% revenue increase to $11.4 million despite challenges such as hurricanes and staffing shortages. For the full year, Paysign projects total revenues between $56.5 million and $58.5 million, with net income expected to be between $3 million and $3.5 million, reflecting a robust growth trajectory well into 2025.Significant Revenue Growth
Revenue for the third quarter was $15.3 million, an increase of 23% compared to the same period in 2023 and a 6.5% increase from the prior quarter.
Patient Affordability Business Expansion
Revenue from the patient affordability business grew by 219% year-over-year, reaching $3.3 million in the third quarter, with claims processed increasing by 430%.
Improved Gross Margins
Gross margins improved by 440 basis points to 55.5% compared to 51.1% in the same period last year.
Strategic Partnerships and Program Growth
The company onboarded several programs from both new and existing clients, including a new account with one of the world's largest pharmaceutical companies.
Strong Cash Position
Exited the quarter with $10.3 million in unrestricted cash and 0 debt.
---
PAYS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PAYS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 05, 2024 | $3.83 | $4.06 | +6.01% |
| Jul 31, 2024 | $5.33 | $4.87 | -8.63% |
| May 07, 2024 | $4.67 | $4.57 | -2.14% |
| Mar 26, 2024 | $3.38 | $4.00 | +18.34% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does PaySign (PAYS) report earnings?
PaySign (PAYS) is schdueled to report earning on Mar 25, 2025, TBA Not Confirmed.
What is PaySign (PAYS) earnings time?
PaySign (PAYS) earnings time is at Mar 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PAYS EPS forecast?
PAYS EPS forecast for the fiscal quarter 2024 (Q4) is 0.02.
---